A Food and Drug Administration review of CardioMEMS’ device for treating heart failure found it has met its main safety and effectiveness goals, based on trial results.
Popular Posts:
- Medical device maker Orthofix cuts restructures
- FDA halts J&J study of pain drug over safety
- Daily aspirin may reduce cancer risk, study shows
- A Case Study of PA 4th CD Rep. Jason Altmire « Beaver County Blue
- Too many women get HPV tests: study